EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, BioMed Realty Trust's enterprise value is $4,846.0 Mil.
BioMed Realty Trust's EBITDA for the trailing twelve months (TTM) ended in Sep. 2015 was $560.9 Mil. Therefore, BioMed Realty Trust's EV-to-EBITDA for today is 8.64.
The historical rank and industry rank for BioMed Realty Trust's EV-to-EBITDA or its related term are showing as below:
BMR's EV-to-EBITDA is not ranked *
in the REITs industry.
Industry Median: 15.35 * Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
BioMed Realty Trust EV-to-EBITDA Historical Data
The historical data trend for BioMed Realty Trust's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioMed Realty Trust's EV-to-EBITDA
For the REIT - Office subindustry, BioMed Realty Trust's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioMed Realty Trust's EV-to-EBITDA Distribution in the REITs Industry
For the REITs industry and Real Estate sector, BioMed Realty Trust's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where BioMed Realty Trust's EV-to-EBITDA falls into.
BioMed Realty Trust's current Enterprise Value is $4,846.0 Mil.
BioMed Realty Trust's EBITDA for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $560.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
BioMed Realty Trust's PE Ratio for today is calculated as:
BioMed Realty Trust's share price for today is $23.81.
BioMed Realty Trust's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.930.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of BioMed Realty Trust's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
BioMed Realty Trust (BioMed Realty Trust) Business Description
BioMed Realty Trust Inc, a Maryland corporation was formed on April 30, 2004 and commenced operations on August 11, 2004, after completing its initial public offering. The Company operates as a self-administered and self-managed real estate investment trust focused on acquiring, developing, owning, leasing and managing laboratory and office space for the life science industry mainly through its subsidiary, BioMed Realty, L.P., a Maryland limited partnership Its tenants mainly include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are generally located in markets with well established reputations as centers for scientific research, including Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/ New Jersey. The Company faces competition from various entities for investment opportunities in properties for life science tenants, including other REITs, such as health care REITs and suburban office property REITs, pension funds, insurance companies, investment funds and companies, partnerships, and developers. The Company's properties are subject to various laws, ordinances and regulations, including regulations relating to common areas.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BMR has been successfully added to your 